Acq Opportunity Promedica International, a California-based ophthalmology-focused CRO with recent acquisition activity, presents a potential partner or integration opportunity for buyers or investors looking to consolidate ophthalmology CRO capabilities and expand regional reach.

Private CRO Operates as a privately held, woman-owned full-service CRO with 35+ years in clinical trials for medical devices, biotech, and pharma, indicating stability and potential for long-term engagements and multi-project collaborations.

Ophthalmology Focus Specialization in ophthalmology CRO services suggests a strong fit for sponsors in eye care treatments and devices; potential upsell of specialized ophthalmic trial design, endpoints, and regulatory support to expand scope with existing clients.

Moderate Scale Employee count and revenue in the small-to-mid market imply agility with shorter sales cycles; suitable for targeted outreach to mid-market sponsors seeking personalized CRO partnerships and flexible resourcing.

Recent Leadership Past enhancement in clinical operations leadership and notable executive hires indicate openness to operational collaboration, co-development of trial strategies, and potential joint ventures to accelerate study delivery.